Zions Bancorporation, National Association’s Genmab GMAB Stock Holding History

Zions Bancorporation, National Association’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$742	Sell	27 -21	-44%	-$558	﹤0.01%	1479
2026 Q1	$1.29K	Buy	48 +21	+78%	+$629	﹤0.01%	1309
2025 Q4	$832	Hold	27	–	–	﹤0.01%	1142
2025 Q3	$828	Buy	27 +4	+17%	+$97	﹤0.01%	823
2025 Q2	$475	Sell	23 -24	-51%	-$493	﹤0.01%	844
2025 Q1	$920	Buy	+47	New	+$986	﹤0.01%	843

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Zions Bancorporation, National Association's GMAB Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Genmab (GMAB) stake by 44% in Q2 2026, selling an estimated $558 and leaving 27 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Zions Bancorporation, National Association first reported a position in GMAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.29K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Zions Bancorporation, National Association held 27 shares of Genmab worth $742 as of Q2 2026.
Zions Bancorporation, National Association sold 21 Genmab shares in Q2 2026, an estimated $558.
Genmab made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1479 holding.
Zions Bancorporation, National Association first reported a position in Genmab in Q1 2025 and has held it in 6 quarters since.
Zions Bancorporation, National Association's Genmab position peaked at $1.29K in Q1 2026.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.